These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 16835480)

  • 41. Analysis of prognostic variables among patients with locally advanced head and neck cancer treated with late chemo-intensification protocol: impact of nodal density and total tumor volume.
    Chufal KS; Rastogi M; Srivastava M; Pant MC; Bhatt ML; Srivastava K
    Jpn J Clin Oncol; 2006 Sep; 36(9):537-46. PubMed ID: 16905755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined-modality treatment for advanced oral tongue squamous cell carcinoma.
    Fan KH; Lin CY; Kang CJ; Huang SF; Wang HM; Chen EY; Chen IH; Liao CT; Cheng AJ; Chang JT
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):453-61. PubMed ID: 17236967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma.
    Gross ND; Ellingson TW; Wax MK; Cohen JI; Andersen PE
    Arch Otolaryngol Head Neck Surg; 2004 Feb; 130(2):169-73. PubMed ID: 14967745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor.
    Klug C; Wutzl A; Kermer C; Ploder O; Sulzbacher I; Selzer E; Voracek M; Oeckher M; Ewers R; Millesi W
    Int J Oral Maxillofac Surg; 2005 May; 34(3):262-7. PubMed ID: 15741034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment results and prognostic factors in locally advanced hypopharyngeal cancer.
    Lee MS; Ho HC; Hsiao SH; Hwang JH; Lee CC; Hung SK
    Acta Otolaryngol; 2008 Jan; 128(1):103-9. PubMed ID: 17851955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
    Harada K; Supriatno ; Kawaguchi S; Kawashima Y; Itashiki Y; Yoshida H; Sato M
    Anticancer Res; 2005; 25(3c):2471-5. PubMed ID: 16080478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity.
    Hiratsuka H; Miyakawa A; Nakamori K; Kido Y; Sunakawa H; Kohama G
    Cancer; 1997 Aug; 80(3):351-6. PubMed ID: 9241067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
    Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
    Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neoadjuvant concurrent radiochemotherapy followed by surgery in advanced oral squamous cell carcinoma (OSCC): a retrospective analysis of 207 patients.
    Freier K; Engel M; Lindel K; Flechtenmacher C; Mühling J; Hassfeld S; Hofele C
    Oral Oncol; 2008 Feb; 44(2):116-23. PubMed ID: 17350327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
    Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
    Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study.
    Kwong DL; Sham JS; Au GK; Chua DT; Kwong PW; Cheng AC; Wu PM; Law MW; Kwok CC; Yau CC; Wan KY; Chan RT; Choy DD
    J Clin Oncol; 2004 Jul; 22(13):2643-53. PubMed ID: 15226332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case of advanced maxillary carcinoma with cervical lymph node metastases showing a complete response to the combination therapy of CDDP, TS-1 and radiation].
    Hino S; Shintani S; Nonaka T; Hara S; Hamakawa H
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):215-7. PubMed ID: 14997754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biweekly paclitaxel, cisplatin, tegafur, and leucovorin as neoadjuvant chemotherapy for unresectable squamous cell carcinoma of the head and neck.
    Wang HM; Liao CT; Chang TC; Chen JS; Liaw CC; Chen IH; Tsang NM
    Cancer; 2004 Oct; 101(8):1818-23. PubMed ID: 15386306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
    Taguchi T; Tsukuda M; Mikami Y; Matsuda H; Tanigaki Y; Horiuchi C; Nishimura G; Nagao J
    Auris Nasus Larynx; 2009 Apr; 36(2):199-204. PubMed ID: 18632233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic predictors of squamous cell carcinoma of the buccal mucosa with negative surgical margins.
    Jing J; Li L; He W; Sun G
    J Oral Maxillofac Surg; 2006 Jun; 64(6):896-901. PubMed ID: 16713803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
    Lee CC; Chu ST; Chou P; Lee CC; Chen LF
    Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A prospective randomized trial of adjuvant chemotherapy with UFT for head and neck carcinoma. Head and Neck UFT Study Group].
    Tsukuda M; Ogasawara H; Kaneko S; Komiyama S; Horiuchi M; Inuyama Y; Uemura T; Uchida M; Kamata S; Okuda M
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1169-77. PubMed ID: 8031158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.